Proteasomal activity decreases with ApoE4 expression. حسب Nathan R. Zuniga (20422428)

Table 6 - Gain and loss: Human and environmental wellbeing – drivers of Kilimanjaro’s decreasing biodiversity حسب Andreas Hemp (730415)

Changes in outcomes over time. حسب Jae-Heung Cho (798319)

"…The CMT group showed significant improvement in specific functional and quality of life measures, particularly in the EuroQoL-VAS (-13.21 (95% confidence interval [CI] -20.03 to -6.38) and the Jaw Functional Limitation Scale-Global score of 0.59 (95% CI 0.13 to 1.05), through improvements were not consistent across all indices. …"

Baseline and post-treatment results of categorical electrocardiographic variables in each study group. حسب Káryta Suely Macêdo Martins (22404155)

الموضوعات:

Line graph showing the values of inflammatory cytokines at baseline and after treatment. حسب Káryta Suely Macêdo Martins (22404155)

الموضوعات:

Baseline and Post-Treatment Myocardial Perfusion Defects Expressed as a Percentage of the Total Left Ventricular Surface Area in Each Experimental Group. حسب Káryta Suely Macêdo Martins (22404155)

الموضوعات:

Baseline and post-treatment results of quantitative electrocardiographic variables in each study group. حسب Káryta Suely Macêdo Martins (22404155)

الموضوعات:

CONSORT diagram illustrating patient flow during the study. حسب Káryta Suely Macêdo Martins (22404155)

الموضوعات:

Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group. حسب Káryta Suely Macêdo Martins (22404155)

الموضوعات:

Illustrative images of the processing of a myocardial perfusion study in a patient with Chagas disease. حسب Káryta Suely Macêdo Martins (22404155)

الموضوعات:

Clinical and Demographic Characteristics of the Study Population. حسب Káryta Suely Macêdo Martins (22404155)

الموضوعات:

Illustrative images of the quantitative processing of polar maps from a myocardial perfusion study in one of the investigated patients. حسب Káryta Suely Macêdo Martins (22404155)

الموضوعات:

Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group. حسب Káryta Suely Macêdo Martins (22404155)

الموضوعات:

Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group. حسب Káryta Suely Macêdo Martins (22404155)

الموضوعات:

Variables obtained from the SF-36 quality of life questionnaire in each experimental group. حسب Káryta Suely Macêdo Martins (22404155)

الموضوعات:

Line graph showing the values of myocardial perfusion defects in the study groups. p = ANOVA Mixed Models. حسب Káryta Suely Macêdo Martins (22404155)

الموضوعات:

Early IL-33 administration expands trTregs and improves disease outcome in infected mice. حسب Santiago Boccardo (5927954)

الموضوعات:

Increased or reduced ATGL-1 activity does not significantly change <i>N. parisii</i> growth. حسب Hala Tamim El Jarkass (16625309)

الموضوعات:

Scatter plots of the relationships between age and the proportions of cells which statistically significantly correlated with age. حسب Arttu Autio-Kimura (20454681)

الموضوعات:

EF-24 treatment induces distinct gene expression changes in Kasumi-1 cells. حسب Ajeet P. Singh (22298432)

الموضوعات: